US Stock MarketDetailed Quotes

ZNTL Zentalis Pharmaceuticals

Watchlist
  • 1.345
  • -0.025-1.82%
Trading Apr 30 11:10 ET
96.59MMarket Cap-0.58P/E (TTM)

Zentalis Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
67.43M
26.87M
0
0
40.56M
0
0
0
0
0
Operating revenue
--67.43M
--26.87M
--0
--0
--40.56M
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
0.37%254.88M
7.44%72.98M
-17.99%51.43M
11.65%65.15M
0.57%65.33M
11.73%253.94M
31.24%67.92M
15.73%62.72M
-8.06%58.35M
12.22%64.95M
Selling and administrative expenses
35.37%87.12M
144.45%40.01M
-8.43%14.61M
7.01%16.76M
-3.84%15.74M
17.96%64.35M
46.93%16.37M
32.81%15.95M
-20.23%15.66M
39.11%16.37M
-General and administrative expense
35.37%87.12M
144.45%40.01M
-8.43%14.61M
7.01%16.76M
-3.84%15.74M
17.96%64.35M
46.93%16.37M
32.81%15.95M
-20.23%15.66M
39.11%16.37M
Research and development costs
-11.51%167.77M
-36.05%32.97M
-21.26%36.82M
13.36%48.39M
2.06%49.59M
9.76%189.59M
26.94%51.56M
10.87%46.77M
-2.60%42.68M
5.36%48.58M
Operating profit
26.18%-187.46M
32.11%-46.11M
17.99%-51.43M
-11.65%-65.15M
61.87%-24.77M
-11.73%-253.94M
-31.24%-67.92M
-15.73%-62.72M
8.06%-58.35M
-12.22%-64.95M
Net non-operating interest income expense
Other net income (expense)
194.85%21.77M
-122.84%-1.56M
56.01%11.25M
44.40%-22.86M
750.52%34.95M
-483.35%-22.95M
111.88%6.85M
278.43%7.21M
-9,797.41%-41.12M
864.55%4.11M
Gain on sale of security
12.76%25.5M
-68.28%2.17M
56.01%11.25M
-613.66%-22.86M
750.52%34.95M
277.77%22.62M
111.88%6.85M
278.43%7.21M
949.76%4.45M
864.55%4.11M
Special income (charges)
91.80%-3.74M
---3.74M
--0
--0
----
---45.57M
--0
--0
---45.57M
----
-Less:Impairment of capital assets
--3.74M
----
----
----
----
--0
----
----
----
----
-Less:Other special charges
----
----
----
----
----
--45.57M
--0
----
--45.57M
----
Income before tax
40.16%-165.69M
21.94%-47.68M
27.61%-40.19M
11.52%-88.01M
116.74%10.18M
-25.12%-276.89M
-25.87%-61.07M
-6.16%-55.51M
-57.79%-99.47M
-5.90%-60.84M
Income tax
129.45%177K
-51.85%-205K
-187.10%-27K
143.97%266K
32.41%143K
-28.14%-601K
62.50%-135K
119.50%31K
-3,658.82%-605K
227.27%108K
Earnings from equity interest net of tax
--0
--0
--0
--0
--0
1.65%-16.01M
--0
--0
-156.73%-13.7M
-31.92%-2.31M
Net income
43.26%-165.87M
22.10%-47.47M
27.70%-40.16M
21.58%-88.28M
115.87%10.04M
-23.28%-292.31M
-10.83%-60.94M
-1.91%-55.54M
-64.59%-112.56M
-6.79%-63.26M
Net income continuous Operations
43.26%-165.87M
22.10%-47.47M
27.70%-40.16M
21.58%-88.28M
115.87%10.04M
-23.28%-292.31M
-10.83%-60.94M
-1.91%-55.54M
-64.59%-112.56M
-6.79%-63.26M
Minority interest income
75.44%-28K
0
0
0
34.88%-28K
62.87%-114K
-69.23%-22K
87.88%-12K
-5.71%-37K
73.13%-43K
Net income attributable to the parent company
43.24%-165.84M
22.07%-47.47M
27.68%-40.16M
21.55%-88.28M
115.93%10.07M
-23.39%-292.19M
-10.82%-60.92M
-2.07%-55.53M
-64.62%-112.53M
-7.01%-63.22M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
43.24%-165.84M
22.07%-47.47M
27.68%-40.16M
21.55%-88.28M
115.93%10.07M
-23.39%-292.19M
-10.82%-60.92M
-2.07%-55.53M
-64.62%-112.53M
-7.01%-63.22M
Basic earnings per share
47.87%-2.33
20.48%-0.66
29.11%-0.56
32.97%-1.24
113.08%0.14
0.22%-4.47
9.78%-0.83
17.71%-0.79
-38.06%-1.85
18.32%-1.07
Diluted earnings per share
47.87%-2.33
20.48%-0.66
29.11%-0.56
32.97%-1.24
113.08%0.14
0.22%-4.47
9.78%-0.83
17.71%-0.79
-38.06%-1.85
18.32%-1.07
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 67.43M26.87M0040.56M00000
Operating revenue --67.43M--26.87M--0--0--40.56M--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 0.37%254.88M7.44%72.98M-17.99%51.43M11.65%65.15M0.57%65.33M11.73%253.94M31.24%67.92M15.73%62.72M-8.06%58.35M12.22%64.95M
Selling and administrative expenses 35.37%87.12M144.45%40.01M-8.43%14.61M7.01%16.76M-3.84%15.74M17.96%64.35M46.93%16.37M32.81%15.95M-20.23%15.66M39.11%16.37M
-General and administrative expense 35.37%87.12M144.45%40.01M-8.43%14.61M7.01%16.76M-3.84%15.74M17.96%64.35M46.93%16.37M32.81%15.95M-20.23%15.66M39.11%16.37M
Research and development costs -11.51%167.77M-36.05%32.97M-21.26%36.82M13.36%48.39M2.06%49.59M9.76%189.59M26.94%51.56M10.87%46.77M-2.60%42.68M5.36%48.58M
Operating profit 26.18%-187.46M32.11%-46.11M17.99%-51.43M-11.65%-65.15M61.87%-24.77M-11.73%-253.94M-31.24%-67.92M-15.73%-62.72M8.06%-58.35M-12.22%-64.95M
Net non-operating interest income expense
Other net income (expense) 194.85%21.77M-122.84%-1.56M56.01%11.25M44.40%-22.86M750.52%34.95M-483.35%-22.95M111.88%6.85M278.43%7.21M-9,797.41%-41.12M864.55%4.11M
Gain on sale of security 12.76%25.5M-68.28%2.17M56.01%11.25M-613.66%-22.86M750.52%34.95M277.77%22.62M111.88%6.85M278.43%7.21M949.76%4.45M864.55%4.11M
Special income (charges) 91.80%-3.74M---3.74M--0--0-------45.57M--0--0---45.57M----
-Less:Impairment of capital assets --3.74M------------------0----------------
-Less:Other special charges ----------------------45.57M--0------45.57M----
Income before tax 40.16%-165.69M21.94%-47.68M27.61%-40.19M11.52%-88.01M116.74%10.18M-25.12%-276.89M-25.87%-61.07M-6.16%-55.51M-57.79%-99.47M-5.90%-60.84M
Income tax 129.45%177K-51.85%-205K-187.10%-27K143.97%266K32.41%143K-28.14%-601K62.50%-135K119.50%31K-3,658.82%-605K227.27%108K
Earnings from equity interest net of tax --0--0--0--0--01.65%-16.01M--0--0-156.73%-13.7M-31.92%-2.31M
Net income 43.26%-165.87M22.10%-47.47M27.70%-40.16M21.58%-88.28M115.87%10.04M-23.28%-292.31M-10.83%-60.94M-1.91%-55.54M-64.59%-112.56M-6.79%-63.26M
Net income continuous Operations 43.26%-165.87M22.10%-47.47M27.70%-40.16M21.58%-88.28M115.87%10.04M-23.28%-292.31M-10.83%-60.94M-1.91%-55.54M-64.59%-112.56M-6.79%-63.26M
Minority interest income 75.44%-28K00034.88%-28K62.87%-114K-69.23%-22K87.88%-12K-5.71%-37K73.13%-43K
Net income attributable to the parent company 43.24%-165.84M22.07%-47.47M27.68%-40.16M21.55%-88.28M115.93%10.07M-23.39%-292.19M-10.82%-60.92M-2.07%-55.53M-64.62%-112.53M-7.01%-63.22M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 43.24%-165.84M22.07%-47.47M27.68%-40.16M21.55%-88.28M115.93%10.07M-23.39%-292.19M-10.82%-60.92M-2.07%-55.53M-64.62%-112.53M-7.01%-63.22M
Basic earnings per share 47.87%-2.3320.48%-0.6629.11%-0.5632.97%-1.24113.08%0.140.22%-4.479.78%-0.8317.71%-0.79-38.06%-1.8518.32%-1.07
Diluted earnings per share 47.87%-2.3320.48%-0.6629.11%-0.5632.97%-1.24113.08%0.140.22%-4.479.78%-0.8317.71%-0.79-38.06%-1.8518.32%-1.07
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
CG MED EQUIP.
838810
+29.98%
BEOKA
870199
+29.96%
Shenzhen Bromake New Material
301387
+20.01%
4
Zhejiang Hongchang Electrical Technology
301008
+20.00%
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
+20.00%
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025